Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Breaking a vicious cycle.

Hayes DF, Allen J, Compton C, Gustavsen G, Leonard DG, McCormack R, Newcomer L, Pothier K, Ransohoff D, Schilsky RL, Sigal E, Taube SE, Tunis SR.

Sci Transl Med. 2013 Jul 31;5(196):196cm6. doi: 10.1126/scitranslmed.3005950.

PMID:
23903752
[PubMed - indexed for MEDLINE]
2.

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Altman DG, McShane LM, Sauerbrei W, Taube SE.

PLoS Med. 2012;9(5):e1001216. doi: 10.1371/journal.pmed.1001216. Epub 2012 May 29.

PMID:
22675273
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Altman DG, McShane LM, Sauerbrei W, Taube SE.

BMC Med. 2012 May 29;10:51. doi: 10.1186/1741-7015-10-51.

PMID:
22642691
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Challenges in drug and biomarker co-development.

Taube SE, Lively T.

Recent Results Cancer Res. 2012;195:229-39. doi: 10.1007/978-3-642-28160-0_21. Review.

PMID:
22527510
[PubMed - indexed for MEDLINE]
5.

Biomarkers in oncology: trials and tribulations.

Taube SE.

Ann N Y Acad Sci. 2009 Oct;1180:111-8. doi: 10.1111/j.1749-6632.2009.05019.x.

PMID:
19906265
[PubMed - indexed for MEDLINE]
6.

A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment.

Taube SE, Clark GM, Dancey JE, McShane LM, Sigman CC, Gutman SI.

J Natl Cancer Inst. 2009 Nov 4;101(21):1453-63. doi: 10.1093/jnci/djp334. Epub 2009 Oct 23.

PMID:
19855077
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A system for sharing routine surgical pathology specimens across institutions: the Shared Pathology Informatics Network.

Drake TA, Braun J, Marchevsky A, Kohane IS, Fletcher C, Chueh H, Beckwith B, Berkowicz D, Kuo F, Zeng QT, Balis U, Holzbach A, McMurry A, Gee CE, McDonald CJ, Schadow G, Davis M, Hattab EM, Blevins L, Hook J, Becich M, Crowley RS, Taube SE, Berman J; Shared Pathology Informatics Network.

Hum Pathol. 2007 Aug;38(8):1212-25. Epub 2007 May 8.

PMID:
17490722
[PubMed - indexed for MEDLINE]
8.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF; American Society of Clinical Oncology/College of American Pathologists.

Arch Pathol Lab Med. 2007;131(1):18-43. doi: 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2.

PMID:
19548375
[PubMed - indexed for MEDLINE]
9.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF; American Society of Clinical Oncology; College of American Pathologists.

J Clin Oncol. 2007 Jan 1;25(1):118-45. Epub 2006 Dec 11.

PMID:
17159189
[PubMed - indexed for MEDLINE]
10.

REporting recommendations for tumor MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of NCI-EORTC Working Group on Cancer Diagnostics.

Breast Cancer Res Treat. 2006 Nov;100(2):229-35. Epub 2006 Aug 24.

PMID:
16932852
[PubMed - indexed for MEDLINE]
11.

Reporting recommendations for tumor marker prognostic studies (remark).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Exp Oncol. 2006 Jun;28(2):99-105.

PMID:
16837898
[PubMed - indexed for MEDLINE]
12.

REporting recommendations for tumor MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Nat Clin Pract Urol. 2005 Aug;2(8):416-22.

PMID:
16482653
[PubMed - indexed for MEDLINE]
13.

Cancer diagnostics: decision criteria for marker utilization in the clinic.

Taube SE, Jacobson JW, Lively TG.

Am J Pharmacogenomics. 2005;5(6):357-64. Review.

PMID:
16336001
[PubMed - indexed for MEDLINE]
14.

Reporting recommendations for tumor marker prognostic studies.

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

J Clin Oncol. 2005 Dec 20;23(36):9067-72. Epub 2005 Sep 19. No abstract available.

PMID:
16172462
[PubMed - indexed for MEDLINE]
15.

REporting recommendations for tumor MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Nat Clin Pract Oncol. 2005 Aug;2(8):416-22.

PMID:
16130938
[PubMed - indexed for MEDLINE]
16.

REporting recommendations for tumour MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Br J Cancer. 2005 Aug 22;93(4):387-91.

PMID:
16106245
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Reporting recommendations for tumor marker prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

J Natl Cancer Inst. 2005 Aug 17;97(16):1180-4.

PMID:
16106022
[PubMed - indexed for MEDLINE]
Free Article
18.

REporting recommendations for tumour MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Eur J Cancer. 2005 Aug;41(12):1690-6.

PMID:
16043346
[PubMed - indexed for MEDLINE]
19.

Program for the Assessment of Clinical Cancer Tests (PACCT): implementing promising assays into clinical practice.

Jessup JM, Lively TG, Taube SE.

Expert Rev Mol Diagn. 2005 May;5(3):271-3. No abstract available.

PMID:
15934805
[PubMed - indexed for MEDLINE]
20.

Prognostic and predictive markers in cancer.

Conley BA, Taube SE.

Dis Markers. 2004;20(2):35-43. Review.

PMID:
15322312
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk